Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease

References

• WoutersEFEconomic analysis of the Confronting COPD survey: an overview of resultsRespir Med200397Suppl CS3S1412647938
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• SestiniPRenzoniERobinsonSPoolePRamFSShort-acting beta 2 agonists for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20024CD00149512519559
   PubMedGoogle Scholar
• Lung Health Study Research GroupEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med2000343261902190911136260
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlugeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• LieskerJJWijkstraPJTen HackenNHKoeterGHPostmaDSKerstjensHAA systematic review of the effects of bronchodilators on exercise capacity in patients with COPDChest2002121259760811834677
   PubMed Web of Science ®Google Scholar
• PaggiaroPLDahleRBakranIFrithLHollingworthKEfthimiouJMulticentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet199835191057737809519948
   PubMed Web of Science ®Google Scholar
• CelliBDecramerMKestenSLiuDMehraSTashkinDPMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
   PubMed Web of Science ®Google Scholar
• LapperreTSSnoeck-StrobandJBGosmanMMEffect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2009151851752719841453
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSLystigTMehraSTashkinDPEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
   PubMed Web of Science ®Google Scholar
• Global Initiative for Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2010)20101117 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed September 16, 2011
   Google Scholar
• VathenenASBrittonJREbdenPCooksonJBWharradHJTattersfieldAEHigh-dose inhaled albuterol in severe chronic airflow limitationAm Rev Respir Dis198813848508552462383
   PubMed Web of Science ®Google Scholar
• BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
   PubMed Web of Science ®Google Scholar
• Gokce KutsalYBarakAAtalayAPolypharmacy in the elderly: a multicenter studyJ Am Med Dir Assoc200910748649019716065
   PubMed Web of Science ®Google Scholar
• AnnegarnJMeijerKPassosVLProblematic activities of daily life are weakly associated with clinical characteristics in COPDJ Am Med Dir Assoc February 152011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• SpruitMAVanderhoven-AugustinIJanssenPPWoutersEFIntegration of pulmonary rehabilitation in COPDLancet20083719606121318177760
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
   PubMedGoogle Scholar
• ScholsAMWoutersEFSoetersPBWesterterpKRBody composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary diseaseAm J Clin Nutr19915324214241989407
   PubMed Web of Science ®Google Scholar
• HernandesNAWoutersEFMeijerKAnnegarnJPittaFSpruitMAReproducibility of 6-minute walking test in patients with COPDEur Respir J201138226126721177838
   PubMed Web of Science ®Google Scholar
• TroostersTGosselinkRDecramerMSix minute walking distance in healthy elderly subjectsEur Respir J199914227027410515400
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
   PubMed Web of Science ®Google Scholar
• NiciLDonnerCWoutersEAmerican Thoracic Society/European Respiratory Society statement on pulmonary rehabilitationAm J Respir Crit Care Med2006173121390141316760357
   PubMed Web of Science ®Google Scholar
• MoenJAntonovKLarssonCAFactors associated with multiple medication use in different age groupsAnn Pharmacother200943121978198519920158
   PubMed Web of Science ®Google Scholar
• IncalziRABelliaVCatalanoFEvaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments: the Salute Respiratoria nell’Anziano (Sa.R.A.) StudyChest2001120373474211555502
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J200219220921611871363
   PubMed Web of Science ®Google Scholar
• MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest1999115495796510208192
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
   PubMed Web of Science ®Google Scholar
• RocheNLepageTBourcereauJTerriouxPGuidelines versus clinical practice in the treatment of chronic obstructive pulmonary diseaseEur Respir J200118690390811829094
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ2000320724512971303
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MolkenMDekhuijzenPNEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet200536594701552156015866309
   PubMed Web of Science ®Google Scholar
• FordPADurhamALRussellREGordonFAdcockIMBarnesPJTreatment effects of low dose theophylline combined with an inhaled corticosteroid in COPDChest201013761338134420299628
   PubMed Web of Science ®Google Scholar
• DavisDO’BrienMAFreemantleNWolfFMMazmanianPTaylor-VaiseyAImpact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?JAMA1999282986787410478694
   PubMed Web of Science ®Google Scholar